Strategic move aims to unlock value, drive innovation, and accelerate digital health growth

In a transformative decision that underscores its commitment to shaping the future of Indian healthcare, Apollo Hospitals Enterprise Ltd. (AHEL) has announced its plan to demerge and spin off its digital health and pharmacy businesses into a separate entity. This strategic restructuring is aimed at unlocking value for shareholders, accelerating digital innovation, and enhancing focus across its diversified business verticals.

The proposed demerger, approved by the Board of Directors, will result in the creation of a standalone company that houses Apollo 24/7, the group’s fast-growing digital health platform, and its integrated pharmacy operations, including the omnichannel pharmacy business. The move will allow each business to pursue its own growth trajectory with sharper strategic focus and operational agility.

Driving the Next Chapter of Healthcare Transformation

Apollo 24/7 has emerged as one of India’s leading digital healthcare platforms, offering teleconsultations, online pharmacy services, diagnostic bookings, health records, and personalized health programs. By carving out the digital health and pharmacy arms, Apollo Hospitals seeks to create a digitally empowered healthcare ecosystem that is agile, scalable, and investment-ready.

Dr. Prathap C. Reddy, Founder & Chairman of Apollo Hospitals Group, commented:

“This strategic move reflects our long-term vision to make healthcare more accessible, personalized, and data-driven. Our digital health and pharmacy businesses have reached a critical mass where they can now grow independently and drive disruptive innovation, not only in India but globally.”

Rationale Behind the Demerger

• Unlocking Shareholder Value: By separating the digital and pharmacy verticals, Apollo aims to create distinct value propositions, improving capital allocation and attracting strategic investors.
• Operational Focus: Independent management teams for each business will enhance execution, customer experience, and innovation.
• Market Opportunities: The digital health and e-pharmacy sectors in India are poised for exponential growth, fueled by rising internet penetration, health-tech adoption, and regulatory reforms.

The new entity is expected to pursue its own funding, partnerships, and technological expansions, while continuing to leverage Apollo’s legacy of clinical excellence and trust.

Seamless Transition and Regulatory Approvals

Apollo Hospitals has assured all stakeholders that the transition will be conducted in a seamless and transparent manner. The demerger plan is subject to statutory and regulatory approvals, including from the National Company Law Tribunal (NCLT), stock exchanges, and shareholders.

Post-demerger, shareholders of Apollo Hospitals are expected to receive proportionate ownership in the new entity. Detailed terms and financial implications will be disclosed in the upcoming investor presentations.

Industry Impact and Future Vision

The spin-off marks a significant moment in India’s health-tech sector, reinforcing Apollo’s leadership in digital-first healthcare delivery. With this move, Apollo is not only preparing to meet the needs of tomorrow’s patient but also shaping the next decade of digital, data-driven, and decentralized healthcare.

Suneeta Reddy, Managing Director of Apollo Hospitals, added:

“Our objective is to create two strong, independent companies that are leaders in their respective domains. This reorganization will help us deepen our innovation focus, expand consumer reach, and continue delivering best-in-class care.”